SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Oct 27, 2026

2. SEC Identification Number

148022

3. BIR Tax Identification No.

000-288-655-000

4. Exact name of issuer as specified in its charter

Euro-Med Laboratories Phil., Inc.

5. Province, country or other jurisdiction of incorporation

Metro Manila

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

PPL Building, United Nations Avenue corner San Marcelino St., Manila Postal Code 1007

8. Issuer's telephone number, including area code

00-63-2-85240091 to 98

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
common shares	4,112,140,540

11. Indicate the item numbers reported herein

Item 9 : Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 6-1 - Declaration of Cash Dividends References: SRC Rule 17 (SEC Form 17-C) and
Sections 6 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Declaration of Cash Dividend
Background/Description of the Disclosure
Please be advised that our Board of Directors at its regular hybrid meeting held today, 27 October 2026 at 4:00 p.m. in which a quorum was present throughout, unanimously approved the declaration of cash dividend in the amount of P0.075 per share from the unrestricted retained earnings of the Corporation as of 31 December 2025, to all stockholders of record as of 13 November 2026 and which shall be paid on 04 December 2026. Thank you.

Type of Securities

• Common
• Preferred-
• Others-

Cash Dividend

Date of Approval by Board of Directors	Oct 27, 2026
Other Relevant Regulatory Agency, if applicable	N/A
Date of Approval by Relevant Regulatory Agency, if applicable	N/A
Type (Regular or Special)	Regulart
Amount of Cash Dividend Per Share	Php0.075
Record Date	Nov 13, 2026
Payment Date	Dec 4, 2026

Source of Dividend Payment
Cash dividend will be sourced from the unrestricted retained earnings of the Corporation as of 31 December 2025.
Other Relevant Information
None